Daily BriefsECM

Daily Brief ECM: CNGR A/H Listing: Healthy A/H Premium and Cheap Valuation and more

In today’s briefing:

  • CNGR A/H Listing: Healthy A/H Premium and Cheap Valuation
  • CNGR Advanced Material H Share Listing (2579 HK): Valuation Insights
  • SHEIN Update: US$2 Bn Net, “Mid-Teens” Revenue Growth Targets Shared | New Challenges in France?
  • PhysicsWallah IPO: Driven by Passion to Educate; Sector Always in Controversy; No View on Valuation
  • Physicswallah IPO – RHP Updates and Thoughts on Valuation
  • Pre-IPO Immvira Bioscience – The Pipeline, the Concerns and the Valuation


CNGR A/H Listing: Healthy A/H Premium and Cheap Valuation

By Nicholas Tan

  • CNGR Advanced Material (300919 CH) is looking to raise up to US$500m in its upcoming Hong Kong IPO.
  • CNGR is a Chinese battery-component producer and a new energy materials company. It is the global leader of nickel-based and cobalt-based pCAM (cathode) for lithium-ion batteries.
  • In this note, we examine the IPO dynamics, and look at the firm’s valuation.

CNGR Advanced Material H Share Listing (2579 HK): Valuation Insights

By Arun George


SHEIN Update: US$2 Bn Net, “Mid-Teens” Revenue Growth Targets Shared | New Challenges in France?

By Daniel Hellberg

  • Reportedly, SHEN recently shared FY25 targets of US$2 bn Net, “mid-teens” sales growth
  • SHEIN faces familiar issues in France, where the company has just opened a physical store
  • The release of new FY25 financial targets suggest SHEIN is progressing towards an IPO 

PhysicsWallah IPO: Driven by Passion to Educate; Sector Always in Controversy; No View on Valuation

By Sreemant Dudhoria,CFA

  • Physicswallah Limited (2076103D IN) IPO opens today – 11 Nov 2025.The issue is a combination of fresh issue of INR 31 billion and offer for sale of INR 3.8 billion.
  • In this insight we discuss about the company, the industry, past controversies in the sector across major players.
  • We finally provide rationale why we do now know what valuation multiple to assign given the various factors.

Physicswallah IPO – RHP Updates and Thoughts on Valuation

By Sumeet Singh

  • Physicswallah Is looking to raise about US$434m in its upcoming India IPO.
  • Physicswallah Ltd (PWL) offers test preparation courses for competitive examinations, and other courses such as for upskilling, across 13 education categories, including JEE, NEET, and UPSC, among others.
  • We have looked at the company’s past performance in our earlier notes. In this note we talk about the RHP updates and provide our thoughts on valuations.

Pre-IPO Immvira Bioscience – The Pipeline, the Concerns and the Valuation

By Xinyao (Criss) Wang

  • The virus carrier process is complex.Cost of MVR-T3011 large-scale production is higher than antibody drugs.The awareness of oncolytic virus among doctors is insufficient. Market competition in engineered exosome is fierce.
  • As a clinical stage company, commercialization of its products is likely to seek business partners through a license-out model. So, how much sales/profit belongs to Immvira remains to be seen.
  • We think a neutral scenario is that valuation could be about US$10-1.2 billion. However, if the clinical data falls short of expectations, the valuation may be halved to US$500 million.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars